Skip to content

Author

Katherine R. Tuttle

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 6316: Inflammatory Risk and Cardio-Renal Outcomes in Adults with Chronic Kidney Disease: A Nationwide Study

Introduction: The prognostic burden of inflammation in chronic kidney disease (CKD) remains poorly characterized, with prior small-scale studies yielding conflicting estimates of the association between elevated C-reactive protein (CRP) and cardio-renal outcomes. Methods: We conducted an observational study of...

Katherine R. Tuttle, F. Mazhar, Minjung Han et al. · 0 citations
Open access Nov 2026

Changes in Metabolic and Blood Pressure Outcomes With Semaglutide Across Chronic Kidney Disease Stages: A Post Hoc Analysis of the FLOW Trial.

AIMS To assess changes in glycated haemoglobin (HbA1c), body weight, and systolic/diastolic blood pressure (SBP/DBP) by chronic kidney disease (CKD) and albuminuria categories in a post hoc analysis of FLOW, an international, double-blind, randomized, phase 3b clinical trial of adults with CKD and Type 2 diabetes (T2D)...

A. Friedman, J. Basile, Robert S. Busch et al. · 0 citations
Open access Aug 2026

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

BACKGROUND AND AIMS Hypertension is a common attributable cause of chronic kidney disease (CKD). Mineralocorticoid receptor overactivation can lead to hypertension and contributes to CKD progression. In FIND-CKD, finerenone reduced kidney function decline in participants with CKD without diabetes. This prespecified FIN...

H. Heerspink, Jelle M. Beernink, R. Agarwal et al. · 0 citations
Open access Oct 2026

High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study.

BACKGROUND AND HYPOTHESIS The burden and prognostic significance of inflammation in chronic kidney disease (CKD) remains poorly characterized, with prior studies yielding conflicting estimates of the association between elevated high-sensitivity C-reactive protein (hsCRP) and cardio-kidney outcomes. METHODS Observati...

F. Mazhar, Minjung Han, Katherine R. Tuttle et al. · 0 citations
Review Open access Sep 2026

Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Inflammatory Biomarkers: A Systematic Review and Meta-Analysis.

BACKGROUND AND AIMS Sodium-glucose cotransporter-2 inhibitors (SGLT2is) improve cardiovascular and kidney outcomes, but their effects on circulating inflammatory biomarkers remain uncertain. We systematically reviewed randomized evidence on the effects of SGLT2is on peripheral-blood inflammatory biomarkers. METHODS P...

Mehmet Kanbay, Ermeena Shah, Rama Al-Shiab et al. · 0 citations
Review Sep 2026

Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes

Investigating treatments for CKD possess anti-inflammatory properties that might contribute to their previously established clinical benefits, including renin-angiotensin-aldosterone system inhibitors, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocortico...

Katherine R. Tuttle, Mehmet Kanbay, Radica Z. Alicic et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.